Medesis Pharma S.A.
ISIN: FR0010844464 | Ticker: ALMDP | LEI: 969500C15M96P00UR648
Country: France
Medesis Pharma is a clinical-stage Pharmaceutical Biotechnology company developing innovative technology (AONYS®) for the delivery of therapeutic molecules to treat diseases with no current efficacious treatment.
Legal structure :
Montpellier (France) Headquarters
Montreal (Canada) 100% subsidiary. Medesis Pharma Inc. is a subsidiary for collaborations with McGill University and the University of Montreal.
2003
Served areaWorldwide
HeadquartersL'Orée des Mas Avenue du Golf, 34670 Baillargues, Montpellier – France
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 21.07.23 | None | Other | Sell | EUR 1,400.00 |
| 04.07.23 | None | Other | Sell | EUR 7,100.00 |
| 23.05.23 | None | Other | Sell | EUR 6,908.00 |
FR0010844464
LEI969500C15M96P00UR648
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.